Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Younger CRSwNP Group

Regeneron、賽諾菲迅速獲得美國食品藥品管理局對年輕的 CrsWNP 集團的 Dupixent 的審查

WSJ · 05/13 06:09

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.